Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 11, 2010, Pages 1651-1656

  Gao, Yu Jie ^a   He, Yu Juan ^a   Yang, Zai Lin ^b   Shao, Hui Yuan ^a   Zuo, Yan ^a   Bai, Yao ^a   Chen, Hui ^a   Chen, Xian Chun ^a   Qin, Feng Xian ^a   Tan, Shi ^a   Wang, Jian ^a   Wang, Li ^a   Zhang, Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute leukemia; Cell free DNA; DNA; Integrity; Plasma

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ADULT; ARTICLE; CALCULATION; CANCER GROWTH; CANCER REGRESSION; CANCER RELAPSE; CELL FREE SYSTEM; CONTROLLED STUDY; DNA INTEGRATION; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; CASE-CONTROL STUDIES; CELL-FREE SYSTEM; DISEASE PROGRESSION; DNA; HUMANS; LEUKEMIA; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78751609365     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.311     Document Type: Article

References (31)

1. Anker P, Stroun M. Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease. Leukemia 2001;15:289-91.
2. Jilani I, Estey E, Manshuri T, Caligiuri M, Keating M, Giles F, et al. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Leukemia 2003;17:114-9.
3. Mueller S, Holdenrieder S, Stieber P, Haferlach T, Schalhorn A, Braess J, et al. Early prediction of therapy response in patients with acute myeloid leukaemia by nucleosomal DNA fragments. BMC Cancer 2006;6:143-52.
4. Papadaki C, Dufour A, Seibl M, Schneider S, Bohlander SK, Zellmeier E, et al. Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor. Br J Haematol 2009;144:517-23.
5. Wong IH, Dennis Lo YM, Johnson PJ. Epigenetic tumor markers in plasma and serum biology and applications to molecular diagnosis and disease monitoring. Ann NY Acad Sci 2001;945:36-50.
6. Tamkovich SN, Vlassov VV, Laktionov PP. Circulating deoxyribonucleic acids in blood and their using in medical diagnostics. Mol Biol (Mosk) 2008;42:12-23.
7. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 1997;278:1054-9.
8. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology 2007;39:197-207.
9. Mandel P, Metais P. Les acides nucleiques du plasma sanguin chez l'homme. C R Acad Sci Paris 1948;142:241-3.
10. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-50.
11. Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa A, et al. Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Bio 2008;27:415-21.
12. Ren N, Ye QH, Qin LX, Zhang BH, Liu YK, Tang ZY, et al. Circulating DNA level is negatively associated with the longterm survival of hepatocellular carcinoma patients. World J Gastroenterol 2006;12:3911-4.
13. Sunami E, Vu AT, Nguyen SL, Giuliano AE, Hoon DS. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer. Ann NY Acad Sci 2008;1137:171-4.
14. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD, et al. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998;17:89-97.
15. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61:1659-65.
16. Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, et al. Increased plasma DNA integrity in cancer patients. Cancer Res 2003;63:3966-8.
17. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 2006;24:4270-6.
18. Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ, et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 2006;52:1062-9.
19. Ellinger J, Wittkamp V, Albers P, Perabo FG, Mueller SC, von Ruecker A, et al. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 2009;181:363-71.
20. Deligezer U, Eralp Y, Akisik EZ, Akisik EE, Saip P, Topuz E, et al. Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer. Ann NY Acad Sci 2008;1137:175-9.
21. Rogers A, Joe Y, Manshouri T, Dey A, Jilani I, Giles F, et al. Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia. Blood 2004;103:2799-801.
22. Schwarz AK, Stanulla M, Cario G, Flohr T, Sutton R, Möricke A, et al. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia. Ann Hematol 2009;88:897-905.
23. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park HL, Westra WH, et al. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer 2006;119:2673-6.
24. Stroun M, Anker P, Lyautey J, Lederrey C, Maurice PA. Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 1987;28:707-12.
25. Wu TL, Zhang D, Chia JH, Tsao KH, Sun CF, Wu JT, et al. Cell-free DNA: measurement in various carcinomas and stablishment of normal reference range. Clin Chim Acta 2002;321:77-87.
26. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop pre-eclampsia. Clin Chem 2001;47:137-9.
27. Chiu TW, Young R, Chan LY, Burd A, Lo DY. Plasma cell-free DNA as an indicator of severity of injury in burn patients. Clin Chem Lab Med 2006;44:13-7.
28. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319-23.
29. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 2007;62:699-702.
30. Deligezer U, Eralp Y, Akisik EE, Akisik EZ, Saip P, Topuz E, et al. Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy. Clin Chem Lab Med 2008;46:311-7.
31. Tomita H, Ichikawa D, Sai S, Morimura R, Murayama Y, Komatsu S, et al. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal and gastric cancer. Gan To Kagaku Ryoho 2007;34:1908-10.